NEWS
2008, April 23th
New technologies available
Semi-synthesis technologies
D-(-)-a-p-hydroxyphenylglycine (chemical plus enzymatic)
D-aminoacids (alanine, serine, phenylalanine, p-Cl-phenylalanine)
Antibiotics
Spiramycin
Virginiamycin
2008, April 15th
Biofin Laboratories will attend
CPhI China
Pudong-Shanghai, 24th-26th June, 2008
CPhI South America
Rio De Janeiro, 19th-21st August, 2008
SERVICES
Technology transfer
with licensing of fermentation and semi-synthesis processes producing:
- Bacteriostatic antibiotic API
- Anticancer API
- Vitamins
- Aminoacids
- Cosmetic Ingredients
- Steroids
- Statins
- Other bioproducts.
Biofin scientists will assist the client in the industrial implementation of the process, in case of client request, assuring confidential assistance.
Process improvements:
- Strain development programmes
- Improvement of industrial procedure
- Optimization of production cost.
Engineering and Consulting:
- Feasibility studies for existing and new processes
- Preliminary basic engineering
- Basic engineering
- Industrial fermenter design
- Process scale-up from laboratory to industrial scale
- Sterile design and evaluation of existing production plants.
The Biofin's knowledge of the practical problems involved in the industrial implementation of fermentation and semisynthesis technologies allows to define the best plant parameters and design, and to face the adaptation of a process to a ready plant.